Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991017750) NICOTINYLALANINE AS A THERAPEUTIC AGENT ACTING ON THE CENTRAL NERVOUS SYSTEM
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/017750 International Application No.: PCT/EP1991/000950
Publication Date: 28.11.1991 International Filing Date: 21.05.1991
Chapter 2 Demand Filed: 18.12.1991
IPC:
A61K 31/455 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
455
Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides
Applicants:
FIDIA S.P.A. [IT/IT]; Via Ponte della Fabbrica 3/A Abano Terme (Padova), IT (AllExceptUS)
PELLICCIARI, Roberto [IT/IT]; IT (UsOnly)
MORONI, Flavio [IT/IT]; IT (UsOnly)
STONE, Trevor, W. [GB/GB]; GB (UsOnly)
Inventors:
PELLICCIARI, Roberto; IT
MORONI, Flavio; IT
STONE, Trevor, W.; GB
Agent:
MINOJA, Fabrizio; Studio Consulenza Brevettuale Via Rossini, 8 I-20122 Milano, IT
Priority Data:
20418 A/9024.05.1990IT
Title (EN) NICOTINYLALANINE AS A THERAPEUTIC AGENT ACTING ON THE CENTRAL NERVOUS SYSTEM
(FR) UTILISATION DE LA NICOTINYLALANINE COMME AGENT THERAPEUTIQUE AGISSANT SUR LE SYSTEME NERVEUX CENTRAL
Abstract:
(EN) Nicotinylalanine or physiologically equivalent derivatives thereof are used for the preparation of a medicament for the treatment of conditions characterised by an abnormal increase in the metabolism of tryptophan and abnormal excitatory neurotransmission.
(FR) La nicotinylalanine ou ses dérivés équivalents sur le plan physiologique sont utilisés pour préparer un médicament servant au traitement d'états caractérisés par une augmentation anormale du métabolisme du tryptophane et par une neurotransmission excitatoire anormale.
Designated States: AU, BB, BG, BR, CA, FI, HU, JP, KP, KR, LK, MC, MG, MW, NO, PL, RO, SD, SU, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, ML, MR, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
NO19924472EP0532545JPH05507086CA2083507AU1991078832